TEANECK, N.J., March 2, 2012 /PRNewswire/ -- Herborium Group,
Inc. (HBRM.PK) www.herborium.com is pleased to announce that the
process of Phase 1 due diligence for the sale of up to 100%
interest to China Health Resources Inc (OTCBB:CHRI) is underway.
"We are very excited to advise that the process has begun and is
moving along smoothly," stated Dr. Agnes P. Olszewski CEO of
Herborium Group
"As we have stated in our Press Release of
02/24/2012 regarding a signed Letter of
Intent with China Health Resource Inc., both parties have
commenced a due diligence process by now. This process
will continue for a duration needed for its
completion by both parties. When this process is
completed and the actual transaction takes place, the
transaction will be promptly announced. While both
parties are truly excited about the
opportunity they are also committed to meet
their fiduciary responsibilities so the due diligence
process is and will be conducted in a most responsible
and professional manner. We are most optimistic of a
smooth transaction and final agreement," concluded Dr.
Olszewski.
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company,
focuses on developing, licensing, and marketing proprietary,
botanical based medicinal products to consumers and healthcare
professionals. The Company uses clinical validation to
establish and maintain a differential advantage. The company sales
its products in the US and Europe.
For more information, please visit www.herborium.com and
www.acnease.com.
One of our most important responsibilities is to communicate
with shareholders in an open and direct manner. Comments are
based on current management expectations, and are considered
"forward-looking statements," generally preceded by words such as
"plans," "expects," "believes," "anticipates," or "intends."
We cannot promise future returns. Our statements reflect our
best judgment at the time, and we disclaim any obligation to update
or alter forward-looking statements as the result of new
information or future events. The Company urges
investors to review the risks and uncertainties contained within
its filings with the OTC Markets and/or Securities and Exchange
Commission.
For more information please inquire:
Investorsrelations@herborium.com
SOURCE Herborium Group, Inc.